• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- WHO switches H1N1 in Southern Hemisphere flu vaccine

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-perspective/2016/09/who-switches-h1n1-southern-hemisphere-flu-vaccine

WHO switches H1N1 in Southern Hemisphere flu vaccine
Filed Under:
Influenza Vaccines
Lisa Schnirring | News Editor | CIDRAP News
| Sep 29, 2016

World Health Organization (WHO) vaccine advisors today recommended changing only the 2009 H1N1 component for the Southern Hemisphere's 2017 flu vaccine, the first change in the H1N1 component since the former pandemic virus became a globally circulating seasonal flu strain.
The newly recommended H1N1 vaccine strain, called A/Michigan/45/2015 replaces the longstanding A/California/7/2009 and is recommended to improve protection against two subclades that have emerged over the past season. However, the seasonal flu vaccines for the Northern Hemisphere, based in the WHO group's recommendation last February, still contain the A/California/7/2009 vaccine strain.
During the Northern Hemisphere's previous flu season, some flu experts in Europe, which experienced a late flu season, raised questions about whether newly emerging H1N1 subgroups were dampening the effect of the vaccine.
The WHO group said in its report today that an analysis of 2009 H1N1 samples collected from February to August showed that the vast majority fell into clade 6B, with most belonging to subclade 6B.1 and a small proportion, mostly from China, belonging to subclade 6B.2.
Routine testing based on ferret sera suggested that recently circulating 2009 H1N1 viruses were antigenically indistinguishable from the longstanding vaccine virus strain. Tests using human sera from vaccinated people of different age-groups, however, found a potential gap in protection among adult samples, with potentially an even more significant protection drop for children's samples.
The WHO recommends the following for the Southern Hemisphere's trivalent vaccines:
  • For H1N1, an A/Michigan/45/2015-like virus
  • For H3N2, an A/Hong Hong/4801/2014-like virus
  • For B, Brisbane/60/2008-like virus (belonging to the Victoria lineage)
For quadrivalent vaccines containing two influenza B strains, the WHO experts recommended adding Phuket/3073/2013-like virus, a Yamagata lineage virus that was the second B component of quadrivalent vaccines for both the Southern Hemisphere's current season and the Northern Hemisphere's 2015-16 season.
See also:
Sep 29 WHO recommendations for 2017 Southern Hemisphere flu vaccine strains
Sep 24, 2015, CIDRAP News story "WHO panel changes 2 strains in Southern Hemisphere flu vaccine"
Feb 11 CIDRAP News scan "Early European flu vaccine estimate finds lower protection against H1N1"
Feb 25 CIDRAP News scan "WHO advisors switch out 2 vaccine strains for 2016-17 flu season"



Share
 
Back
Top Bottom